Vitamin D disappoints in trial for infant diarrhea (Reuters, 11 September 2013)
Use of Electronic Health Records Associated With Higher Rate of Detection of Growth Disorders in Children (JAMA, 10 September 2013)

Sanofi, Zealand hit by U.S. setback for diabetes drug (Reuters, 12 September 2013)

12 Sept 2013

French drugmaker Sanofi and Danish partner Zealand Pharma have announced the withdrawal of a US marketing application for lixisenatide, to resubmit when results from a cardiovascular study become available, expected in 2015.

Full article

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read